Venmax Drugs And Pharmaceuticals Ltd Q1 FY26 Results
VENMAXQ1 FY26 ResultsAnnounced 23 Jul 2025, 03:41 pm| Metric | Value (₹ Cr) | vs Q4 FY25 |
|---|---|---|
| Revenue | 1.21 | 263.7% |
| Total Income | 1.21 | 10.7% |
| Expenditure | 1.17 | 101.8% |
| PBT | 0.04 | 95.2% |
| Net Profit | 0.04 | 95.2% |
| OPM | 3.18% | 77.31pp |
| NPM | 3.09% | 54.30pp |
| EPS | 0.07 | 95.3% |
Venmax Drugs Reports Q1 2025 Profit Growth of 77.82 Crores INR
23 Jul 2025 · 23 Jul 2025, 03:43 pm
Summary
Venmax Drugs and Pharmaceuticals Ltd. has reported a profit growth of 77.82 Crores INR for the quarter ended 30th June, 2025. The financial results are reviewed and recommended by the Audit Committee and approved by the Board of Directors.
Key Highlights
- 1
Q1 2025 profit growth of 77.82 Crores INR
- 2
Revenue from operations: 121.03 Crores INR
- 3
Profit before Exceptional items and tax: 3.74 Crores INR
- 4
Profit for the period from continuing operations: 77.82 Crores INR
- 5
The company operates in a single segment
Management Comments
N
Not Available
The text does not provide any management comments.
Informational and educational content only. Not investment advice.